Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole' Study

Int J Obes Relat Metab Disord. 2003 Oct;27(10):1242-9. doi: 10.1038/sj.ijo.0802373.

Abstract

Objective: To compare the effects of a standard American diet, a traditional low-fat diet, and a low-fat diet containing the fat substitute olestra on risk factors for heart disease and diabetes.

Design: A 9-month, double-blind, randomized, parallel-arm, feeding study comparing three diets: (1). control (33% fat), (2). fat-reduced (FR; 25% fat), and (3). fat-substituted (FS) where olestra replaced 1/3 of dietary fat (33% lipid and 25% digestible fat). Subjects were allowed to adjust their total energy intake as desired, allowing weight to fluctuate.

Subjects: A total of 37 healthy, obese men (age 36.7+/-1.3 y; body mass index 30.8+/-0.4 kg/m(2)).

Measurements: Body weight and composition by dual-energy X-ray absorptiometry, blood pressure, serum lipids, lipoproteins, hemostatic factors, glucose, insulin, and leptin at baseline and every 3 months.

Results: The FS group lost 6.27 kg of body weight by 9 months vs 4.0 kg in the control and 1.79 kg in the FR groups. There was a significant diet main effect on cholesterol (P=0.002), low-density lipoprotein cholesterol (P=0.003), and triglycerides (P=0.01), all of which decreased in the FS group but not the other groups by 9 months. Apolipoprotein B (ApoB) increased in the FR and control groups but was unchanged in the FS group (diet main effect P=0.04). High-density lipoprotein (HDL) cholesterol increased in all groups over 9 months (time main effect P=0.0001). Time main effects were also observed for cholesterol, ApoA1, ApoB, Factor VII, diastolic blood pressure, and glucose. After adjustment for % fat loss at 9 months, the effects of diet on change in risk factors remained significant only for triglycerides.

Discussion: Consumption of a low-fat diet containing olestra for 9 months produced significant improvement in cardiovascular risk factors, an effect largely explained by weight loss. Long-term low-fat diet consumption with or without olestra does not decrease HDL cholesterol.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Apolipoproteins / blood
  • Blood Glucose / analysis
  • Cholesterol / blood
  • Cholesterol, LDL / blood
  • Diet, Fat-Restricted / methods*
  • Dietary Fats, Unsaturated / administration & dosage
  • Double-Blind Method
  • Fat Substitutes / administration & dosage*
  • Fatty Acids / administration & dosage*
  • Humans
  • Insulin / blood
  • Leptin / blood
  • Male
  • Obesity / blood
  • Obesity / complications
  • Obesity / diet therapy*
  • Risk Factors
  • Sucrose / administration & dosage*
  • Sucrose / analogs & derivatives*
  • Triglycerides / blood
  • Weight Loss / drug effects

Substances

  • Apolipoproteins
  • Blood Glucose
  • Cholesterol, LDL
  • Dietary Fats, Unsaturated
  • Fat Substitutes
  • Fatty Acids
  • Insulin
  • Leptin
  • Triglycerides
  • Sucrose
  • sucrose polyester
  • Cholesterol